Veracyte
VCYT
111 hedge funds and large institutions have $340M invested in Veracyte in 2018 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 45 increasing their positions, 16 reducing their positions, and 2 closing their positions.
1,800% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 2
181% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 16
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
48% more funds holding
Funds holding: 75 → 111 (+36)
47% more capital invested
Capital invested by funds: $231M → $340M (+$108M)
18.04% more ownership
Funds ownership: 72.14% → 90.18% (+18%)
Top Buyers
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
+$39.9M |
| 2 |
BlackRock
New York
|
+$10M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$8.33M |
| 4 |
Goldman Sachs
New York
|
+$7.43M |
| 5 |
PC
Pier Capital
Stamford,
Connecticut
|
+$7.08M |
Top Sellers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$17.3M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$7.2M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$2.06M |
| 4 |
Morgan Stanley
New York
|
-$1.19M |
| 5 |
Millennium Management
New York
|
-$862K |
VCYT Hedge Fund Activity: Q3 2018 in Review
111 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2018, worth a combined $340M — up 47% from $231M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new VCYT positions and 2 closed out — a net gain of 36 holders — while 45 added to existing stakes and 16 trimmed.
The largest buyer was Versant Venture Management, opening a new position worth an estimated $39.9M. The largest seller was Acuta Capital Partners, cutting an estimated $17.3M.
- 111 institutional investors held Veracyte (VCYT) as of Q3 2018, up from 75 in Q2 2018.
- Funds reported $340M of Veracyte stock for Q3 2018, up 47% quarter-over-quarter.
- 38 funds opened new Veracyte positions in Q3 2018 and 2 closed out, a net change of +36 holders.
- The largest Veracyte buyer in Q3 2018 was Versant Venture Management, an estimated $39.9M added.
- The largest Veracyte seller in Q3 2018 was Acuta Capital Partners, an estimated $17.3M sold.
Based on aggregated 13F filings for Q3 2018.